Literature DB >> 2599103

Limited proteolysis of C1-inhibitor by chymotrypsin-like proteinases.

O L Schoenberger1, J L Sprows, N M Schechter, B S Cooperman, H Rubin.   

Abstract

Limited proteolysis of C1-inhibitor was observed with human skin chymase, human cathepsin G, and bovine chymotrypsin. In each case, the inhibitor was degraded to one major product migrating slightly faster than the native inhibitor in an SDS-polyacrylamide gel. The inhibitory activity of C1-inhibitor against human plasma kallikrein was not altered by the modification with chymase. Edman degradation of the proteolyzed inhibitor revealed two sequences in a 1:1 ratio: NPNATSSSQ, the N-terminus of native C1-inhibitor, and VEPILEVSSL. This second sequence showed that the Phe33-Val34 bond was hydrolyzed. Our results provide another example of the susceptibility of the N-terminal region of C1-inhibitor to proteolytic cleavage.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2599103     DOI: 10.1016/0014-5793(89)81519-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Chymotrypsin inhibitory activity of normal C1-inhibitor and a P1 Arg to His mutant: evidence for the presence of overlapping reactive centers.

Authors:  K S Aulak; A E Davis; V H Donaldson; R A Harrison
Journal:  Protein Sci       Date:  1993-05       Impact factor: 6.725

2.  Degradation of C1-inhibitor by plasmin: implications for the control of inflammatory processes.

Authors:  E M Wallace; S J Perkins; R B Sim; A C Willis; C Feighery; J Jackson
Journal:  Mol Med       Date:  1997-06       Impact factor: 6.354

3.  Interaction of human mast cell tryptase and chymase with low-molecular-mass serine proteinase inhibitors from the human respiratory tract.

Authors:  K Hochstrasser; W Gebhard; G Albrecht; G Rasp; E Kastenbauer
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

4.  Plasma Proteolytic Cascade Activation during Neonatal Cardiopulmonary Bypass Surgery.

Authors:  Susan A Maroney; Julie A Peterson; Wes Zwifelhofer; Nicholas D Martinez; Ke Yan; Rachel S Bercovitz; Ronald K Woods; Alan E Mast
Journal:  Thromb Haemost       Date:  2018-08-07       Impact factor: 5.249

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.